SSY GROUP (02005) obtained the drug production registration certificate for sodium glycerophosphate injection (10ml:2.16g).

ShiSi Pharmaceutical Group (02005) announced that the group has obtained the drug production registration certificate for sodium glycerophosphate injection (10ml:2.16g) from the China National Medical Products Administration. This drug belongs to the category 4 of chemical drugs, and is considered to have passed consistency evaluation. It is the third domestic enterprise to receive approval. Sodium glycerophosphate injection is a nutritional medicine mainly used as a phosphorus supplement for adult parenteral nutrition and for patients with phosphorus deficiency.